John Kerr posted in cancer • EPA • HSNO • immunotherapy • liver cancer • Pexa-Vec • virology • virus on October 29th, 2015.
The Environmental Protection Authority (EPA) has approved the use of a genetically modified virus (Pexa-Vec) for a liver cancer treatment trial. The Pexa-Vec virus is the first genetically modified organism for a human therapeutic purpose that is capable of reproducing itself, to be approved by the EPA for release under the HSNO Act. In a separate media release Environment Minister […]
Continue reading “UPDATED: GMO virus approved for cancer trial – Expert reaction”